Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

3 Medical Devices Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of three Medical Devices stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Why Online Sales Growth Won’t Save JCP — In One Chart

By Alyssa Oursler, InvestorPlace Contributor
JCP has been touting strong online sales growth, which is nice ... but it won't be enough to help JCPenney stock.

12 “Triple F” Stocks to Sell

By Portfolio Grader
This week, 12 stocks get F's ("strong sell") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade.

16 Oil and Gas Stocks to Sell Now

By Portfolio Grader
This week, the ratings of 16 Oil and Gas stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Electrical Equipment Stocks to Sell Now

By Portfolio Grader
This week, the overall grades of five Electrical Equipment stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Poor Analyst Earnings Revisions — BONT VRTX PSEM TRNX UEC

By Portfolio Grader
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

5 Internet and Web Service Stocks to Sell Now

By Portfolio Grader
The overall ratings of five Internet and Web Service stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Chemicals Stocks to Sell Now

By Portfolio Grader
The ratings of four Chemicals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

By Portfolio Grader
This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Should I Buy Yum Brands? 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor
Yum Brands stock plunged 7% yesterday, in the wake of disappointing earnings. Does the stock have a chance of turning around, or should investors avoid YUM?

SHLD: Same Fate as JCPenney, It’s Just Taking a Different Route

By James Brumley, InvestorPlace Feature Writer
JCPenney (JCP) and Sears (SHLD) are more alike than different in their woes. It's just that one of the retailers is willing to buy time by shooting itself in the foot.

10 Worst “Strong Sell” Stocks This Week — EXK EGO NG and more

By Portfolio Grader
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader. Since the beginning of the year, the Nasdaq rose 10.9%, the Dow is up 13.2%, and the S&P has risen 12.1%.

5 Stocks With Crummy Earnings Surprises — WPC CBB ROMA MOD NX

By Portfolio Grader
This week, these five stocks have the worst ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

6 Energy Services Stocks to Sell Now

By Portfolio Grader
This week, the ratings of six Energy Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Software Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of four Software stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Construction and Engineering Stocks to Sell Now

By Portfolio Grader
The overall ratings of three Construction and Engineering stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biotech Blowout: 3 Stocks Taking a Hit

By Adam Benjamin, InvestorPlace Assistant Editor
The risky side of biotech stocks reared its ugly head in the past couple of days, sending three stocks to the mat in the wake of bad news.

Quality Is King This Q3 Earnings Season

By Louis Navellier, Editor, Growth Investor
Quality is going to matter during Q3 earnings season. Don't be caught owning the wrong stocks at what could be a devastatingly wrong time.

4 Stocks With Awful Earnings Momentum — FNBN NAV SGK LGCY

By Portfolio Grader
This week, these four stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.
Load More Articles